Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer.
about
Primary analysis of the phase II component of a phase I/II dose intensification study using three-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117.Long-term disease-free survival of patients with primary cardiac lymphoma treated with systemic chemotherapy and radiotherapyRadiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer.Management of normal tissue toxicity associated with chemoradiation (primary skin, esophagus, and lung).Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer.Integrating stereotactic body radiation therapy in stage II/III non-small cell lung cancer: is local control important?Role of surgery in N2 NSCLC: pros.Tracheo-parenchymal fistula following concurrent chemo-radiation for stage III NSCLC.Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial.Fluoroscopically guided balloon dilation for benign bronchial stricture occurring after radiotherapy in patients with lung cancer.Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.
P2860
Q33897625-1F3825AF-A929-4E01-9A92-0D745F099852Q34501114-BE988DA5-A392-404F-B5F8-F93A4433DB2AQ35971034-1479750C-56CB-4A86-8910-DD394704146BQ36811458-E1EEBB9C-0372-4C45-BD33-88E732128228Q37333649-30450777-BFBA-45CA-8EE6-CF9F693D3BB6Q38243178-B2A8309A-2B57-4504-A739-849C199EF708Q38961401-1B8EDCAE-B5DD-4D45-AD9F-4D6294ECAC30Q40475149-4A3AF1F4-0503-4E54-B057-5752C2AD5487Q41686423-E2645DD8-AE92-49BC-AD87-3708C5739635Q46042376-38A62426-657C-4715-A2CA-CEF5C74CD017Q48707805-06D613D8-9FC5-4279-937E-09CDA1D346D4
P2860
Late complications of high-dose (>/=66 Gy) thoracic conformal radiation therapy in combined modality trials in unresectable stage III non-small cell lung cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Late complications of high-dos ...... II non-small cell lung cancer.
@en
Late complications of high-dose
@nl
type
label
Late complications of high-dos ...... II non-small cell lung cancer.
@en
Late complications of high-dose
@nl
prefLabel
Late complications of high-dos ...... II non-small cell lung cancer.
@en
Late complications of high-dose
@nl
P2093
P1476
Late complications of high-dos ...... II non-small cell lung cancer.
@en
P2093
Carrie B Lee
David E Morris
Dominic T Moore
Julian G Rosenman
M Patricia Rivera
Mark A Socinski
Thomas E Stinchcombe
P356
10.1097/JTO.0B013E3181915028
P577
2009-01-01T00:00:00Z